Trial
NCT01807156
Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Emory University
Collaborators
AVEO Pharmaceuticals, Inc.
Condition
Hepatocellular Cancer
Intervention
Tivozanib
Why stopped
Primary endpoint not met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-04-22